TY - JOUR
T1 - Flavin-containing reductase
T2 - New perspective on the detoxification of nitrobenzodiazepine
AU - Linwu, Shiuan Woei
AU - Wang, Andrew H.J.
AU - Peng, Fu Chuo
N1 - Funding Information:
This work was supported by grants from the National Science Council of Taiwan, ROC (NSC95-2320-B-002-100 to F-C Peng and NSC97-3112-B-001-017 to AH-J Wang). The authors state no conflicts of interests and have received no payment in the preparation of this manuscript.
PY - 2010/8
Y1 - 2010/8
N2 - Importance of the field: Nitrobenzodiazepines (NBDZs) are important hypnotic-sedative drugs prescribed in clinic for treating sleeping disorders. The long-lasting efficacy of NBDZs has made them to be used purposely resulting in neurophysiological impairment and internal toxicity. While many studies have investigated the biotransformation of NBDZs, studies seldom are found on their reductive metabolism or the enzymes that act on these drugs. Areas covered in this review: In this review, we describe the finding of human hepatic NADPH-cytochrome P450 reductase (EC 1.6.2.4) and Escherichia coli nitroreductase NfsB (EC 1.5.1.34) in the reductive conversion of NBDZ to a harmless metabolite 7-aminobenzodiazepine and present the facts of reductive activity in other flavin-containing reductases. A historic investigation on the reduction of nitroaromatics and quinones by the selected flavoenzymes is performed. In addition, flavin domain structures of these enzymes are discussed. What the reader will gain: The reader will gain a comprehensive understanding of the reductive metabolism of NBDZs including the structureactivity relationship of the selected flavoproteins. Take home message: The discovery of novel flavin-containing reductase on NBDZ in the body is essential for the development of more active nitroreductases which may find applications in the detoxification of NBDZ.
AB - Importance of the field: Nitrobenzodiazepines (NBDZs) are important hypnotic-sedative drugs prescribed in clinic for treating sleeping disorders. The long-lasting efficacy of NBDZs has made them to be used purposely resulting in neurophysiological impairment and internal toxicity. While many studies have investigated the biotransformation of NBDZs, studies seldom are found on their reductive metabolism or the enzymes that act on these drugs. Areas covered in this review: In this review, we describe the finding of human hepatic NADPH-cytochrome P450 reductase (EC 1.6.2.4) and Escherichia coli nitroreductase NfsB (EC 1.5.1.34) in the reductive conversion of NBDZ to a harmless metabolite 7-aminobenzodiazepine and present the facts of reductive activity in other flavin-containing reductases. A historic investigation on the reduction of nitroaromatics and quinones by the selected flavoenzymes is performed. In addition, flavin domain structures of these enzymes are discussed. What the reader will gain: The reader will gain a comprehensive understanding of the reductive metabolism of NBDZs including the structureactivity relationship of the selected flavoproteins. Take home message: The discovery of novel flavin-containing reductase on NBDZ in the body is essential for the development of more active nitroreductases which may find applications in the detoxification of NBDZ.
KW - Escherichia coli nitroreductase NfsB
KW - Flavin-containing reductase
KW - NADPH-cytochrome P450 reductase
KW - Nitrobenzodiazepine
KW - Rational enzyme design
UR - http://www.scopus.com/inward/record.url?scp=77954841657&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77954841657&partnerID=8YFLogxK
U2 - 10.1517/17425255.2010.482928
DO - 10.1517/17425255.2010.482928
M3 - Review article
C2 - 20504108
AN - SCOPUS:77954841657
SN - 1742-5255
VL - 6
SP - 967
EP - 981
JO - Expert Opinion on Drug Metabolism and Toxicology
JF - Expert Opinion on Drug Metabolism and Toxicology
IS - 8
ER -